Author: saak_2002@yahoo.co.uk

Ureteric strictures and other urological conditions often require the placement of ureteric stents to relieve obstruction and maintain ureteral patency. Metallic ureteric stents have gained popularity due to their unique properties, offering advantages over traditional polymeric stents. 

Metallic ureteric stents are typically composed of biocompatible metals such as nickel-titanium alloy (Nitinol). These stents exhibit several advantages, including resistance to encrustation, reduced migration rates, and improved longevity compared to polymeric stents. The Memokath and Allium stents are two widely used types of metallic ureteric stents.

Ureteric strictures, either intrinsic or extrinsic, pose a significant challenge in urological practice. Metallic ureteric stents, such as the Memokath and Allium stents, have demonstrated efficacy in managing these strictures by providing durable and long-term relief of obstruction.

Use of Memokath Stent: 

a. Memokath Stent Design and Placement: The Memokath stent is a self-expandable, thermo-expandable metallic stent that can be placed endoscopically. It consists of a flexible nickel-titanium alloy (Nitinol) mesh, which allows for easy insertion and adjustment to the ureter’s anatomy. 

b. Applications of Memokath Stent: The Memokath stent has shown promising results in the management of various urological conditions, including ureteric strictures. Studies have reported successful stent placement, improved symptoms, and long-term patency rates.

Use of Allium Stent:

a. Allium Stent Design and Placement: The Allium stent is a shape-memory metallic stent that can be deployed endoscopically. It is composed of Nitinol and is characterized by its spiral shape and open-cell structure, which promotes tissue ingrowth and reduces migration. 

b. Applications of Allium Stent: The Allium stent has demonstrated positive outcomes in the treatment of benign ureteric strictures. Studies have reported high technical success rates, improved quality of life, and prolonged patency of the ureter with the Allium stent.

Long-Term Data on Metallic Ureteric Stents: 

a. Safety Profile: Several studies have assessed the safety of metallic ureteric stents over extended periods. Long-term data indicate a low incidence of adverse events, including migration, encrustation, and ureteral injury. 

b. Efficacy and Patency: Long-term follow-up studies have reported favorable results with metallic ureteric stents, showing high patency rates and symptom improvement in patients with ureteric strictures.

Conclusion:

Metallic ureteric stents, such as the Memokath and Allium stents, offer a valuable alternative in the management of ureteric strictures and other urological conditions. These stents demonstrate excellent long-term patency, low migration rates, and improved patient outcomes. Further research and randomized controlled trials are necessary to consolidate the existing data and expand the applications of metallic ureteric stents in benign conditions.

References:

Elsamra O, Leavitt DA, Motato H, et al. Ureteral stenting in the era of novel metallic stents. Urology. 2018;121:9-15.

Pham A, Dario T, Alameddine M, et al. Memokath ureteral stent for the treatment of benign and malignant ureteral strictures. Urology. 2017;109:198-204.

Ziemba JB, Matlaga BR. Novel metallic ureteral stents. Transl Androl Urol. 2019;8(Suppl 3):S292-S299.

Vanni AJ, Zargar H, Rastinehad AR, et al. Novel urologic imaging tools for minimally invasive interventions. Urol Clin North Am. 2020;47(4):471-486.

Benign prostatic hyperplasia (BPH) is a condition that involves the enlargement of the prostate gland, which can lead to urinary problems such as difficulty in starting urination, weak urine flow, and frequent urination. The pathophysiology of BPH involves several complex mechanisms, which are detailed below:

Hormonal changes: The prostate gland is regulated by androgens, which are male sex hormones such as testosterone and dihydrotestosterone (DHT). As men age, the levels of testosterone decrease while the levels of DHT increase, which leads to an enlargement of the prostate gland.

Inflammation: Chronic inflammation in the prostate gland may contribute to the development of BPH. Inflammation can cause the prostate gland to produce growth factors, which stimulate the growth of prostate cells.

Smooth muscle hypertrophy: BPH can also involve the growth and enlargement of smooth muscle cells in the prostate gland. This can cause an increase in the tone of the prostate gland, which can lead to urinary obstruction.

Increased tissue stiffness: The prostate gland becomes stiffer as it enlarges, which can contribute to the compression of the urethra and urinary obstruction.

Obstruction of the urethra: The enlarged prostate gland can obstruct the flow of urine through the urethra, leading to urinary symptoms such as difficulty starting urination, weak urine flow, and frequent urination.

Bladder dysfunction: Over time, the obstruction of the urethra can cause the bladder to become overactive and hypertrophied, which can lead to urinary retention, urinary tract infections, and other complications.

In summary, BPH is a complex condition that involves several mechanisms including hormonal changes, inflammation, smooth muscle hypertrophy, increased tissue stiffness, urethral obstruction, and bladder dysfunction. These mechanisms can lead to the urinary symptoms associated with BPH and can cause complications if left untreated.

If you demonstrate symptoms of bladder outflow obstruction, then the best course would be to visit a urologist for a full assessment.

Urine dipstick analysis is a simple and quick diagnostic tool used to detect the presence of various substances in urine, such as blood, protein, glucose, ketones, and nitrites. The dipstick is a plastic strip with small chemical pads that change color in response to the presence of specific substances in the urine.

To perform a urine dipstick analysis, a healthcare provider or a patient can dip the stick into a urine sample and then compare the color changes on the stick to a color chart that comes with the dipstick. The color changes indicate the presence or absence of various substances in the urine.

A positive urine dipstick for hematuria (blood in urine) is a relevant finding that should be followed up by further evaluation. While a positive dipstick test for hematuria does not necessarily indicate a serious medical condition, it can be an indicator of various underlying conditions, ranging from minor issues to more serious diseases.

A positive urine dipstick for hematuria can be caused by a number of factors, such as urinary tract infections, kidney stones, bladder or kidney cancer, prostate problems, or medications. According to the American Cancer Society, approximately 10% of people with hematuria have cancer, with the most common types being bladder, kidney, or prostate cancer. However, other conditions such as urinary tract infections, kidney stones, and medications can also cause hematuria.

Further diagnostic testing, such as a urine culture, imaging studies (such as ultrasound, CT scan or MRI), cystoscopy or a biopsy may be necessary to determine the underlying cause of the hematuria and rule out cancer or other serious conditions.Therefore, further testing and evaluation are needed to determine the underlying cause and develop an appropriate treatment plan.

It is important to promptly follow up with a healthcare provider if you have any symptoms of hematuria or if you have a positive dipstick test, as early detection and treatment can improve outcomes for many conditions, including cancer.

Recurrent urinary tract infections (UTI’s) are a common problem among women, with up to 50% experiencing at least one episode in their lifetime. Recurrent UTIs are defined as two or more infections in six months or three or more infections in one year. This review aims to provide a comprehensive overview of recurrent UTIs in women and evidence-based management.

Causes of Recurrent UTIs:

The most common cause of recurrent UTI’s is reinfection by the same bacterial strain. Other risk factors for recurrent UTI’s include sexual activity, use of certain contraceptives, menopause, pregnancy, urinary tract abnormalities, and immune system deficiencies.

Diagnosis of Recurrent UTI’s:

The diagnosis of recurrent UTI’s is made by the presence of typical symptoms such as dysuria, urinary frequency, urgency, and lower abdominal pain, coupled with a positive urine culture with significant bacteriuria. If a woman has recurrent UTI’s, she should undergo a thorough evaluation, which includes a urinalysis, urine culture, and imaging studies to rule out urinary tract abnormalities.

Management of Recurrent UTIs:

a. Non-Pharmacological Management:

Non-pharmacological interventions for preventing recurrent UTI’s include adequate hydration, regular urination, wiping front to back after urination, avoiding irritants such as spermicides and feminine hygiene sprays, and avoiding prolonged use of urinary catheters.

b. Pharmacological Management:

Antibiotic prophylaxis is the primary pharmacological intervention for the prevention of recurrent UTI’s. Nitrofurantoin, trimethoprim-sulfamethoxazole, and fosfomycin are the most commonly used antibiotics for prophylaxis.

Treatment of Acute Episodes:

The management of acute episodes of recurrent UTI’s is similar to that of an initial UTI. Treatment typically involves a short course of antibiotics for three to five days.

Postcoital prophylaxis:

Postcoital prophylaxis is a pharmacological intervention for women with recurrent UTI’s triggered by sexual activity. Women take a single dose of an antibiotic immediately after sexual intercourse to prevent infection.

Immunoprophylaxis:

Immunoprophylaxis with oral or intravaginal administration of lactobacillus has shown promising results in preventing recurrent UTI’s.

Conclusion:

Recurrent UTI’s are a common problem among women, and a thorough evaluation is necessary to identify the underlying risk factors. Non-pharmacological interventions should be considered first, and antibiotic prophylaxis can be used in selected women. The choice of antibiotic should be based on local resistance patterns, and postcoital prophylaxis can be considered for women with UTI’s triggered by sexual activity. Further research is needed to determine the optimal duration of prophylaxis, the role of immunoprophylaxis, and other non-antibiotic strategies for the prevention of recurrent UTI’s in women.

Renal stones, also known as kidney stones or urinary calculi, have been documented in medical literature for thousands of years. The ancient Egyptians wrote about urinary stones in medical texts, and Hippocrates, the father of Western medicine, also described the condition.

Kidney stones are formed when certain substances in the urine (such as calcium, oxalate, and uric acid) become concentrated and crystallize. These crystals can grow in size and form solid, stone-like structures. The exact causes of kidney stones are not fully understood, but several factors can increase the risk of developing them, including:

a. Dehydration: Not drinking enough water can cause urine to become concentrated, making it easier for stones to form.

b. Diet: Eating a diet high in salt, animal protein, and oxalate-rich foods (such as spinach, rhubarb, and nuts) can increase the risk of stone formation.

c. Genetics: Some people are more prone to kidney stones due to genetic factors.

d. Medical conditions: Certain medical conditions, such as hyperparathyroidism and Crohn’s disease, can increase the risk of developing kidney stones.

The symptoms of kidney stones can include severe pain in the back, side, or lower abdomen, as well as nausea, vomiting, and blood in the urine. Treatment options can vary depending on the size and location of the stones, but may include pain management, medication to help pass the stones, or surgical procedures.

Prevention of kidney stones involves several strategies, including:

a. Drinking plenty of water: Staying well hydrated can help prevent stones from forming by diluting urine and flushing out substances that could lead to stone formation.

b. Dietary changes: Eating a balanced diet that’s low in salt and animal protein, and limiting oxalate-rich foods, can help prevent stone formation.

c. Medication: Depending on the type of stone, medication may be prescribed to help prevent their formation.

d. Lifestyle changes: Maintaining a healthy weight and getting regular exercise can also help prevent the formation of kidney stones.

In summary, while kidney stones have been documented throughout history, our understanding of their causes and prevention strategies have improved over time. By staying hydrated, eating a balanced diet, and making lifestyle changes as needed, it’s possible to reduce the risk of developing kidney stones.

Vasectomy is a safe and highly effective method of male contraception. It involves the surgical cutting or sealing of the vas deferens, the tubes that transport sperm from the testes to the urethra. This procedure prevents the release of sperm during ejaculation, ensuring contraception without affecting sexual function or hormone production. In this comprehensive review, we will explore the benefits and risks of vasectomy as a contraceptive option, based on current medical research and evidence.

Benefits of Vasectomy:

High Efficacy: Vasectomy is one of the most reliable methods of contraception available to men. The failure rate is extremely low, with a reported effectiveness of over 99.9%. Once the procedure is successful and confirmed by post-operative semen analysis, couples can enjoy long-term, worry-free contraception.

Permanent Contraception: Vasectomy is intended to be a permanent form of contraception. While vasectomy reversal is possible, it should be considered a more complex and expensive procedure, with varying success rates. Therefore, vasectomy is recommended for individuals who are certain they do not wish to have more children.

Non-Hormonal Method: Unlike many other contraceptive methods, vasectomy does not rely on hormones to prevent pregnancy. This makes it an appealing option for men who may experience adverse effects from hormonal contraceptives.

Short Procedure: Vasectomy is typically an outpatient procedure that takes approximately 15-30 minutes. It can be performed under local anesthesia, reducing the risks associated with general anesthesia.

Minimal Interference with Sexual Function: Vasectomy does not affect a man’s ability to have an erection, orgasm, or ejaculation. It only prevents sperm from being present in the semen.

Risks of Vasectomy:

Surgical Risks: As with any surgical procedure, vasectomy carries some risks, albeit low. These risks include bleeding, infection, and scrotal hematoma (accumulation of blood in the scrotum).

Post-operative Pain: Some men may experience mild to moderate discomfort or pain in the scrotum following the procedure. This usually resolves within a few days to a week.Sperm Granuloma: Occasionally, a small, harmless lump called a sperm granuloma may form at the site where the vas deferens was sealed or cut. It usually resolves on its own or may require treatment if it causes persistent discomfort.

Risk of Failure: While vasectomy is highly effective, there is still a small risk of failure, especially in the first few months after the procedure. Until a follow-up semen analysis confirms the absence of sperm, alternative contraception should be used.

Psychological Impact: For some men, the decision to undergo permanent sterilization may have psychological implications, such as anxiety or regret. Pre-operative counseling is essential to address these concerns and ensure informed consent.

Conclusion: Vasectomy is a safe and highly effective form of permanent contraception for men. It offers numerous benefits, such as high efficacy, non-hormonal contraception, and minimal interference with sexual function. While it is generally well-tolerated, vasectomy carries some surgical risks, post-operative discomfort, and the possibility of failure. However, when performed by skilled healthcare professionals and combined with appropriate pre-operative counseling, vasectomy remains a reliable choice for men seeking a permanent contraceptive solution.

References:

1. Shih G, Turok DK, Parker WJ. Vasectomy: Overview and Patient Counseling. In: Mauck C, editor. UpToDate. Waltham, MA: UpToDate Inc.; 2021. Available from: www.uptodate.com.

2. Sharlip ID, Belker AM, Thomas AJ, et al. Best practice policies for male sterilization. Fertil Steril. 2002;77(5):873-882.

3. World Health Organization. Vasectomy: A technical note on male sterilization. Geneva: World Health Organization; 1992.

4. American Urological Association. Vasectomy: AUA guideline. Linthicum, MD: American Urological Association; 2015.